Z00–Z99: Factors Influencing Health Status and Contact with Health Services
Chapter 21 of ICD-10-CM 2027, 1,861 codes in 15 blocks.
Advertisements
Codes in this chapter
All codesBillable only1,861 results
- Z78.0Asymptomatic menopausal state
- Z78.1Physical restraint status
- Z78.9Other specified health status
- Z79Long term (current) drug therapy
- Z79.0Long term (current) use of anticoagulants and antithrombotics/antiplatelets
- Z79.01Long term (current) use of anticoagulants
- Z79.02Long term (current) use of antithrombotics/antiplatelets
- Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2Long term (current) use of antibiotics
- Z79.3Long term (current) use of hormonal contraceptives
- Z79.4Long term (current) use of insulin
- Z79.5Long term (current) use of steroids
- Z79.51Long term (current) use of inhaled steroids
- Z79.52Long term (current) use of systemic steroids
- Z79.6Long term (current) use of immunomodulators and immunosuppressants
- Z79.60Long term (current) use of unspecified immunomodulators and immunosuppressants
- Z79.61Long term (current) use of immunomodulator
- Z79.62Long term (current) use of immunosuppressant
- Z79.620Long term (current) use of immunosuppressive biologic
- Z79.621Long term (current) use of calcineurin inhibitor
- Z79.622Long term (current) use of Janus kinase inhibitor
- Z79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624Long term (current) use of inhibitors of nucleotide synthesis
- Z79.63Long term (current) use of chemotherapeutic agent
- Z79.630Long term (current) use of alkylating agent
- Z79.631Long term (current) use of antimetabolite agent
- Z79.632Long term (current) use of antitumor antibiotic
- Z79.633Long term (current) use of mitotic inhibitor
- Z79.634Long term (current) use of topoisomerase inhibitor
- Z79.64Long term (current) use of myelosuppressive agent
- Z79.69Long term (current) use of other immunomodulators and immunosuppressants
- Z79.8Other long term (current) drug therapy
- Z79.81Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811Long term (current) use of aromatase inhibitors
- Z79.818Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- Z79.82Long term (current) use of aspirin
- Z79.83Long term (current) use of bisphosphonates
- Z79.84Long term (current) use of oral hypoglycemic drugs
- Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
- Z79.89Other long term (current) drug therapy
- Z79.890Hormone replacement therapy
- Z79.891Long term (current) use of opiate analgesic
- Z79.899Other long term (current) drug therapy
- Z80Family history of primary malignant neoplasm
- Z80.0Family history of malignant neoplasm of digestive organs
- Z80.1Family history of malignant neoplasm of trachea, bronchus and lung
- Z80.2Family history of malignant neoplasm of other respiratory and intrathoracic organs
- Z80.3Family history of malignant neoplasm of breast
- Z80.4Family history of malignant neoplasm of genital organs
